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Introduction
Morbid obesity and its related comorbidities are 
increasing universally [1]. Bariatric surgery is now 
the most effective and durable method in weight 
loss and resolution of obesity-related comorbidities 
in the morbidly obese population. Roux-en-Y gastric 
bypass (RYGB) is the second most common proce-
dure among bariatric operations worldwide [2–5], 
with excellent results in excess weight loss (70–
80%) and resolution of weight-related comorbidities 
within the first 2 postoperative years [6]. 
Different findings have been obtained about the 
effect of biliopancreatic limb (BPL) and alimentary 
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A b s t r a c t
Introduction: Roux-en-Y gastric bypass (RYGB) is one of the safe and easily reproducible bariatric procedures.
Aim: To evaluate the effect of biliopancreatic limb (BPL) and alimentary limb (AL) length on weight loss outcomes 
after RYGB.
Material and methods: This retrospective cohort study included 313 morbidly obese patients who underwent pri-
mary laparoscopic RYGB 2009–2015. Patients’ BPL and AL lengths were categorized into three groups: group 1 (BPL: 
50 cm and AL: 150 cm), group 2 (BPL: 150 cm and AL: 50 cm), and group 3 (BPL: 100 cm and AL: 100 cm). Data were 
provided from the Iranian National Obesity Surgery Database. The generalized estimating equations method was 
used to assess the effect of limbs length on %excess weight loss (%EWL).
Results: Mean ± standard deviation age and body mass index (BMI) of 252 patients were 38.55 ±10.24 years and 
45.8 ±4.77 kg/m2, respectively. Totally, 172 (68.3%, BMI of 46 ±5 kg/m2), 48 (19%, BMI of 45.12 ±4.26 kg/m2), and 
32 (12.7%, BMI of 45.43 ±4.23 kg/m2) were in group 1, 2, and 3, respectively (p = 0.44). The results showed that the 
choice of different limb lengths had no significant effect on %EWL over 12 months follow-up (p = 0.625) adjusted for 
baseline BMI (p = 0.25). Mean %EWL in the patients with longer BPL and shorter AL was 5.43% (1.91, 8.95) higher in 
comparison to the patients with shorter BPL and longer AL during 36 months postoperatively adjusted for baseline 
BMI (p = 0.002).
Conclusions: During 12 months after RYGB, %EWL was not associated with BPL or AL length. However, during 
36 months postoperatively, the patients with longer BPL had a significantly higher %EWL in comparison to the pa-
tients with shorter BPL.
Key words: weight loss, Roux-en-y gastric bypass, biliopancreatic limb, alimentary limb, generalized estimating equa-
tions.
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limb (AL) length on the outcomes of RYGB patients 
[6–11], and there is not yet any consensus on the 
appropriate length of the BPL, AL, and common limb. 
Previous studies have reported contradictory results 
in efficacy of these limb lengths to achieve the best 
results in weight loss outcomes and the prevention 
of nutritional complications. 
Aim
The aim of this study is to determine the effect 
of BPL and AL lengths on the trend of excess weight 
loss and body mass index (BMI) change at short- 
and medium-term (12 and 36 months, respectively) 
follow-up after RYGB. Finally, the proportion of com-




This retrospective cohort study included 313 mor-
bidly obese patients who underwent primary lapa-
roscopic RYGB surgery, between January 2009 and 
March 2015. All of the procedures were performed 
by a single surgery team. Note that from 2013, the 
team had a  tendency to bypass a  longer BPL due 
to the experience of weight regain in patients. We 
included only patients older than 18 years old, with 
BMI > 40 kg/m² or BMI > 35 kg/m² along with at least 
one major comorbidity, with at least 12 months fol-
low-up after surgery. Patients who had re-operation 
including conversion, reversal, and revision due to 
weight loss failure, and female patients who became 
pregnant after the surgery were excluded from the 
study. Data were provided from the National Obesi-
ty Surgery Database, Iran. Written informed consent 
was obtained from all patients before the surgery. 
The ethics committee of Iran University of Medical 
Sciences approved the study (code: IR.IUMS.REC 95-
02-140-27472).
Variables
The included variables were sex, age, height, 
preoperative weight and BMI, comorbidities (hyper-
tension, type 2 diabetes mellitus (T2DM), impaired 
glucose tolerance (100 < FBS ≤ 125), dyslipidemia, 
hypothyroidism, musculoskeletal pain (low-back 
and knee), sleep apnea, cardiovascular disease), 
complications, and the time of follow-up postop-
eratively. The patients’ weight were registered at 
10 days and 1, 3, 6, 9, 12, 18, 24 and 36 months 
after surgery.
Patients’ BPL and AL lengths were measured by 
marked graspers with 5 cm by 5 cm measurement 
and categorized into three groups as follows: group 1 
(BPL: 40–60 cm and AL: 120–150 cm); group 2 
(BPL: 120–150 cm and AL: 40–60 cm); and group 
3 (BPL: 95–105 cm and AL: 95–105 cm) for conve-
nience.
The main outcomes of the study were %excess 
weight loss (%EWL) and change in BMI (∆BMI) cal-
culated from %EWL = ((initial weight) – (postopera-
tive weight)) × 100/((initial weight) – (ideal weight)) 
where ideal weight is defined by the weight cor-
responding to a BMI of 25 kg/m2, and ∆BMI = ini-
tial BMI – postoperative BMI, respectively [12]. 
Weight loss failure was defined as %EWL < 50% at 
18 months postoperatively [13]. Leak, bleeding, hy-
poalbuminemia (defined as at least one occurrence 
of albumin < 3.5 mg/dl), and death were reported 
as complications. Complications were reported ac-
cording to early (≤ 30 days) and late (> 30 days) 
occurrence. Ursodeoxycholic acid 300 mg was rou-
tinely prescribed twice daily for 6 months after the 
surgery. In order to look for gallstones, sonography 
was performed at the 6th month and annually post-
operatively.
Statistical analysis
Qualitative and quantitative variables were re-
ported as number (%) and mean ± standard devi-
ation (SD), respectively. ANOVA and independent 
sample t-test were used to compare the quantitative 
variables between the groups. The c2 and Fisher ex-
act tests were performed to compare the categorical 
variables between the groups. The generalized esti-
mating equation method was used to assess the ef-
fect of the factors on weight loss outcome [14]. The 
results were reported using mean difference (95% 
confidence interval) adjusted for baseline measure-
ment and time as the concomitant variable. The 
data were analyzed using SPSS software v. 16.0 (IBM 
Corp., Armonk, NY, USA). P-values less than 0.05 
were considered as significant.
Results
Twelve patients who became pregnant after the 
surgery were excluded from the study. Forty-nine 
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patients with BPL and AL lengths out of prespeci-
fied groups were excluded from the study. Then, 252 
morbidly obese patients were included in the anal-
ysis. The mean ± SD age of the patients was 38.55 
±10.24 years and 209 (83%) patients were female. 
The numbers (%) of patients in groups 1, 2, and 
3 were 172 (68.3%), 48 (19%), and 32 (12.7%), re-
spectively. Patients’ mean ± SD weight and BMI were 
124.03 ±19 kg and 45.81 ±4.77 kg/m2, respectively.
Table I shows that the mean ± SD age of the pa-
tients was homogeneous between the three groups 
(p = 0.96). No significant difference was found in 
preoperative mean ± SD BMI between the groups 
(p = 0.44, Table I). Median (interquartile range) 
for follow-up time was 59.55 (50.62–68.4), 19.75 
(15.86–25.81), and 14.01 (13.36–15.63) months for 
groups 1, 2, and 3, respectively. 
Patients’ reported comorbidities at first visit were 
homogeneous between the groups except T2DM 
(p = 0.012) and sleep apnea (p = 0.035), which were 
more common in group 1. Follow-up rates were 90%, 
88%, 88%, 88%, 84%, 86%, 70%, 66%, and 62% at 
10 days and 1, 3, 6, 9, 12,18, 24, and 36 months 
after the surgery, respectively. Group 3 was excluded 
from the 36-month analysis.
Sensitivity analysis revealed that the character-
istics including baseline weight and BMI, sex, co-
morbidities, and follow-up time of the patients who 
were excluded from and included in the study were 
not significantly different (results not shown).
%EWL
Figure 1 shows that the trend of mean %EWL of 
the patients with longer BPL is higher compared to 
the patients with shorter BPL. This difference was 
not statistically significant, except at 3 and 6 months 
after the surgery (Table II). 
Table III demonstrates that there is no signif-
icant difference in %EWL in group 1 (p = 0.625) 
and group 2 (p = 0.250) in comparison to group 3 
over 12 months follow-up controlling for baseline 
BMI. Table III shows that the patients with lower 
BMI at baseline had a  significantly higher %EWL 
(p < 0.001). 
Table I. Patients’ reported comorbidities at first visit and other characteristics of the patients in terms  








Age, mean ± SD [years] 38.44 ±10.50 38.73 ±9.54 38.90 ±10.200 0.96
Preoperative weight, mean ± SD [kg] 125.70 ±19.9 119.67 ±16.11 121.50 ±17.20 0.11
Preoperative BMI, mean ± SD [kg/m2] 46.00 ±5.00 45.12 ±4.26 45.43 ±4.23 0.44
Sex (female), n (%) 144 (57.1) 39 (15.5) 26 (10.3) 0.88
Preoperative BMI, n (%):
< 50 kg/m2 134 (53.2) 41 (16.3) 28 (11.1) 0.289
≥ 50 kg/m2 38 (15.1) 7 (2.8) 4 (1.6)
Comorbidities, n (%):
Hypertension 37 (21.5) 8 (16.7) 5 (15.6)
T2DM 25 (16.3) 1 (4) 8 (2.4) 0.012
IGT¶ 41 (23.8) 10 (20.8) 6 (18.8) 0.776
Dyslipidemia 84 (80.5) 20 (22.5) 14 (15) 0.633
Hypothyroidism 42 (39) 10 (11) 5 (7.2) 0.522
Pain (low-back and knee) 182 (72.2) 64 (25.5) 31 (9.3) 0.112
Sleep apnea 18 (7) 10 (4) 8 (3.2) 0.035
Cardiovascular disease 8 (3.2) 1 (0.4) 4 (1.6) 0.097
†BPL – 50 cm and AL – 150 cm, ‡BPL – 150 cm and AL – 50 cm, §BPL – 100 cm and AL– 100 cm, T2DM – type 2 diabetes mellitus, ¶100 < FBS ≤ 125.
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Mean %EWL was not statistically significant be-
tween the groups 36 months postoperatively (Table II, 
p = 0.076). Table IV shows that %EWL mean in the 
patients in group 1 was 5.43% lower in comparison 
to the patients in group 2 over 36 months after the 
surgery adjusted for baseline BMI (p = 0.002). Mean 
%EWL was 8.25% higher in the patients with pre-
operative BMI < 50 kg/m2 compared to the patients 
with preoperative BMI ≥ 50 kg/m2, a significant dif-
ference (p < 0.001, Table IV).
∆BMI 
All the patients’ mean ± SD ∆BMI reached 15.41 
±4.01 at the 12th month after the surgery and remained 
relatively without change afterward (results not shown). 
Patients’ BMI change was not significantly different be-
tween groups in various follow-up times (Table II).
The different limb length groups had no significant 
effect on ∆BMI during 12 months postoperatively, ad-
justed for baseline BMI (p = 0.42, p = 0.68, Table II). 
Patients with lower baseline BMI had a  significantly 
lower change in BMI (–2.65 kg/m2, p < 0.001, Table III).
At 36 months postoperatively, the mean ∆BMI 
of the patients was not statistically significant be-
Figure 1. The trend of %EWL of the patients in 


















 0 4 8 12 16 20 24 28 32 36
Time [month]
 Group 1: BPL 50, AL 150         Group 2 : BPL 150, AL 50
 Group 3: BPL 100, AL 100
Table II. %EWL and ∆BMI of patients in limb length groups at different time points postoperatively
Time 
point 
%EWL, mean ± SD ∆BMI, mean ± SD
Group 1† Group 2‡ Group 3§ P-value Group 1 Group 2 Group 3 P-value






0.052 3.06 ±1.51 3.21 ±0.93 2.5 ±1.11 0.106






0.139 5.02 ±1.73 5.26 ±1.3 4.67 ±1.94 0.391






0.01 8.98 ±2.6 9.61 ±1.92 9.81 ±2.37 0.155






0.012 12.09 ±3.31 12.66 ±2.7 12.53 ±3.44 0.529






0.063 14.03 ±3.65 14.59 ±3.55 13.41 ±4.72 0.537






0.359 15.45 ±3.98 15.39 ±4.12 15 ±3.94 0.928




– 0.114 16.08 ±4.3 15.95 ±3.55 – 0.888




– 0.074 15.9 ±4.3 16.64 ±4.44 – 0.587




– 0.076 15.06 ±4.58 17.49 ±2.31 – 0.167
†BPL – 50 cm and AL – 150 cm, ‡BPL – 150 cm and AL – 50 cm, §BPL – 100 cm and AL – 100 cm, D – day, M – month, ANOVA was used for comparisons 
≤ 12 months and independent sample t-test was used for comparisons afterwards; none of the Ps were significant.
tween the groups (p = 0.167, Table II). In addition, 
Table IV reveals that ∆BMI was significantly lower 
in group 1 in comparison to group 2 controlling for 
baseline BMI (–0.8 kg/m2, p = 0.007). Patients who 
had preoperative BMI < 50 kg/m2 experienced a low-
er ∆BMI (–3.07 kg/m2, p = 0.001, Table IV).
Complications
Table V shows that 2 (0.8%) patients died ear-
ly: one patient due to sepsis because of a leak from 
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gastrojejunostomy three days after the surgery and 
one patient due to fulminant hemolysis which led to 
multi-organ failure (due to anaphylaxis reaction to 
cephalosporins). Four patients experienced a  leak; 
5 (2%) patients had obstruction which resulted in 
readmission and were treated with surgery.
Two (0.8%) patients died late due to non-surgery 
related reasons. Hypoalbuminemia was observed 
in 8 (3.2%) cases. Gallstone and intolerance of the 
bariatric surgery were not reported. Patients’ com-
plaints of smelly stool, constipation, dry skin, and 
hair loss were significantly different between the 
limb length groups. Weight loss failure was observed 
in 11 (4.4%) cases.
Discussion
Despite the invention of new bariatric surgical 
procedures, RYGB has been considered as a  gold 
standard procedure which is malabsorptive and re-
strictive [10, 15]. The impact of BPL and AL lengths 
on RYGB outcomes is still controversial regarding 
appropriate limb lengths [6, 8, 10, 11, 15–18], de-
spite the established relationship between patients’ 
height and total small bowel length [15].
In our study, there was no significant difference 
in weight loss outcomes between different limb 
length groups over 12 months after RYGB. However, 
%EWL was significantly higher in the patients with 
longer BPL and shorter AL during 36 months postop-
eratively. Feng et al. found that long and short Roux 
limbs had no significant effect on %EWL and %BMI 
loss, one year after RYGB in morbidly obese patients 
with BMI < 50 kg/m² [16]. Inabnet et al. found that 
the mean %EWL in 2 years follow-up did not have 
a  significant association with longer BPL (100  cm 
vs. 50  cm) and only internal herniation was more 
common in the group with longer BPL [9]. A report 
by Kaska et al. revealed that there was no signifi-
cant difference in BMI in RYGB patients with long 
BPL (100–150 cm) and short BPL (50–75 cm) 2 years 
after the surgery [8]. Another study also showed the 
non-significant effect of BPL and AL on total weight 
loss 12 months after RYGB [11]. These studies had 
a  compatible finding with our unadjusted and ad-
Table III. The effect of three limb length groups on outcomes over 12 months follow-up
Variable %EWL ∆BMI
Mean difference|| (95% CI) P-value Mean difference (95% CI) P-value
Limb length group:
Group 1† –1.05 (–5.3, 3.19) 0.625 –0.37 (–1.28, 0.53) 0.42
Group 2‡ 2.85 (–2.01, 7.71) 0.25 0.2 (–0.8, 1.2) 0.68
Group 3§ – –
Time 5.13 (4.92, 5.34) < 0.001 1.04 (0.99, 1.08) < 0.001
Baseline BMI (< 50 vs. ≥ 50) 6.85 (3.83, 9.88) < 0.001 –2.65 (–3.41, –1.88) < 0.001
†BPL – 50 cm and AL – 150 cm, ‡BPL – 150 cm and AL – 50 cm, §BPL – 100 cm and AL – 100 cm, ||If 95% confidence interval excludes the value of 0 it is sta-
tistically significant.
Table IV. The effect of two limb length groups with outcomes over 36 months follow-up
Factor %EWL ∆BMI
Mean difference§ (95% CI§) P-value Mean difference (95% CI) P-value
Limb length group:
Group 1† –5.43 (–8.95, –1.91) 0.002 –0.88 (–1.52, –0.24) 0.007
Group 2‡ – –
Time 1.6 (1.5, 1.7) < 0.001 0.32 (0.3, 0.34) < 0.001
Baseline BMI (< 50 vs. ≥ 50) 8.25 (4.59, 11.93) < 0.001 –3.07 (–3.97, –2.17) < 0.001
†BPL – 50 cm and AL – 150 cm, ‡BPL – 150 cm and AL – 50 cm, §|If 95% confidence interval excludes the value of 0 it is statistically significant.
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justed (for time and baseline BMI) results, demon-
strating no significant association between limb 
length and either %EWL or BMI change.
On the other hand, similar to our findings in 
36 months postoperatively, Nergaard et al. observed 
that long BPL (200 cm) had more significant weight 
loss in comparison to short BPL (60 cm), 18 months 
after RYGB, which was persistent in follow-ups for 
7 years [6]. It is also reported that %EWL at 
18 months was greater in patients with a shorter AL 
(100 cm) in BMI < 50 kg/m2 compared with a longer 
AL (150 cm) in patients with BMI > 50 kg/m2; how-
ever, %EWL did not differ after 24 months follow-up 
[10], which may be related to the BMI difference in 
morbidly obese and super-obese patients. In our 
study, the direction of association between limb 
length and %EWL as well as BMI change was similar 
to both studies. The findings of the present study 
showed that the association between %EWL and 
limb length was not significant over a  short-term 
follow-up, whereas it was significant over a  mid-
term follow-up. Moreover, we have incorporated the 
effect of time as well as patient’s BMI at the base-
line in the analysis.





Group 3§  
(n = 32)
P-value
Early (≤ 30 days):
Death 2 (0.8) 0 0 1
Leak 3 (1.2) 1 (0.4) 0 1
Bleeding 5 (2) 0 0 0.63
ICU required (postoperative) 11(0.44) 3 (1.2) 0 0.39
Obstruction|| 5 (2) 0 0 0.63
Pouch dilatation 2 (0.8) 0 0 1
Wound infection 1 (0.4) 0 0 1
Intra-abdominal abscess 1 (0.4) 0 0 1
Late (> 30 days):
Death 2 (0.8) 0 0 1
Hypoalbuminemia¶ 6 (2.4) 2 (0.8) 0 0.64
Dumping 36 (14.4) 5 (2) 8 (3.2) 0.18
Smelly stool 57 (22.8) 25 (10) 16 (12.4) 0.023
Stricture 1 (0.4) 0 0 1
Stomal ulcer 1 (0.4) 0 0 1
GERD 0 1 (0.4) 1 (0.4) 0.1
Hernia 1 (0.4) 0 0 1
Vomiting 28 (11.2) 6 (12.5) 8 (0.25) 0.32
Constipation 5 (2) 12 (4.8) 14 (5.6) < 0.001
Diarrhea 13 (5.2) 8 (3.2) 6 (2.4) 0.057
Dry skin 5 (2) 16 (12.4) 16 (12.4) < 0.001
Hair loss 5 (2) 25 (10) 21 (8.4) < 0.001
†BPL – 50 cm and AL – 150 cm, ‡BPL – 150 cm and AL – 50 cm, §BPL – 100 cm and AL – 100 cm, ||Obstruction that resulted in readmission and treated by surgery, 
¶Albumin < 3.5 mg/dl, GERD – gastroesophageal reflux disease.
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Another study by Gleysteen et al. compared 
three different lengths of AL limb groups (41–61 cm, 
130–160 cm, 115–250 cm about one third of total 
bowel length) with five years follow-up. They found 
that longer AL has better weight loss outcomes only 
in super-obese (BMI > 50 kg/m²) patients, not in 
morbidly obese patients, and also concluded that 
there is no need to measure whole small bowel 
length [7]. Moreover, Ciovica et al. found that longer 
AL (150 cm) had a greater effect on weight loss and 
%EWL in the 1st year after RYGB compared to short-
er AL (100 cm) [18]. The findings of these studies 
are completely different from our study. In most of 
these studies, small bowel length was not measured 
like in our study. So, this controversy between differ-
ent studies should be interpreted with caution be-
cause of the essential role of common channel limb 
length on weight regain, which has been ignored.
Similar studies concluded that the length of AL 
and BPL has no significant impact on complications 
and nutritional deficiencies after RYGB [9, 16, 17]. 
The reason for these different results may be the 
wide variety in choice of limb length, the number 
of patients, the method of data analysis, and fol-
low-up duration. The lack of difference between 
the three groups in %EWL (at 12 months) was likely 
due to type II error which occurred because of the 
small sample size in group 2. Limited follow-up in 
the group 3 patients, limb length variety within the 
groups (which could have resulted in residual con-
founder), small sample size at 36 months follow-up, 
and lack of measurement of the entire small bowel 
length, which is quite variable among people, are 
limitations of this study. 
Conclusions
There was no significant relationship between 
the length of BPL and AL and weight loss outcomes 
over short-term follow-up (12 months); however, the 
patients with longer BPL and shorter AL length had 
a greater weight loss regarding %EWL and BMI change 
over mid-term follow-up (36 months) after RYGB.
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